Provided by Tiger Fintech (Singapore) Pte. Ltd.

LivaNova PLC

54.08
-0.2000-0.37%
Volume:2.45K
Turnover:133.05K
Market Cap:2.95B
PE:-13.91
High:54.29
Open:54.29
Low:54.07
Close:54.28
52wk High:58.91
52wk Low:32.48
Shares:54.60M
Float Shares:54.41M
Volume Ratio:0.51
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8890
EPS(LYR):1.17
ROE:-17.87%
ROA:5.12%
PB:2.63
PE(LYR):46.39

Loading ...

LivaNova Plc Outlook FY 2025 Revenue to Grow Between 8.0% and 9.0% on Constant-Currency Basis

THOMSON REUTERS
·
Aug 06

LivaNova Plc - Initiates CMS Process for Vns Therapy Coverage

THOMSON REUTERS
·
Aug 06

LivaNova Plc Outlook FY 2025 Adj Diluted EPS in Range of $3.70 to $3.80

THOMSON REUTERS
·
Aug 06

LivaNova Outlook FY Revenue Growth 8-9%

THOMSON REUTERS
·
Aug 06

LivaNova Plc - Raised FY 2025 REV, Adj EPS, Adj Free Cash Flow Guidance

THOMSON REUTERS
·
Aug 06

Livanova plc to Announce Second-Quarter 2025 Results

Reuters
·
Jul 09

LivaNova plc Conducted Annual General Meeting with Shareholder Votes Cast

Reuters
·
Jun 12

BRIEF-Livanova Announces Core-Vns 24-Month Data Show Adjunctive Vns Therapy Is Associated With Substantial Reductions In Generalized Tonic-Clonic Seizures In People With Drug-Resistant Epilepsy

Reuters
·
Jun 05

LivaNova PLC Seeks Reconsideration of National Coverage for VNS Therapy in Treatment-Resistant Depression from U.S. CMS

Reuters
·
Jun 04

Italian Ministries Ask for More Fines on LivaNova

Dow Jones
·
May 22

LivaNova PLC Faces Ongoing Legal Battle Over Environmental Liabilities as Italian Supreme Court Refers Case Back to Court of Appeal

Reuters
·
May 22

LivaNova Raised to Outperform From Peer Perform by Wolfe Research

Dow Jones
·
May 21

Wolfe Upgrades LivaNova to Outperform From Peer Perform, Price Target is $60

MT Newswires Live
·
May 20

LivaNova to Present at Jefferies Global Healthcare Conference in New York

Reuters
·
May 15

LivaNova Price Target Maintained With a $64.00/Share by Needham

Dow Jones
·
May 13

LivaNova Is Maintained at Outperform by Baird

Dow Jones
·
May 08

LivaNova Up Nearly 19%, on Pace for Largest Percent Increase Since November 2006 -- Data Talk

Dow Jones
·
May 07

Stock Track | LivaNova Soars 12.12% on Strong Q1 Results, Raised Guidance, and Positive Sleep Apnea Study Data

Stock Track
·
May 07

LivaNova Q1 Adjusted Earnings, Net Revenue Rise; 2025 Outlook Revised

MT Newswires Live
·
May 07

Stock Track | LivaNova Soars 10.64% Pre-Market on Strong Q1 Results and Positive Sleep Apnea Study Data

Stock Track
·
May 07